| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-05 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0003 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.22 | 0.0003 |